XYREM

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Turkey, United Kingdom, United States

Active ingredients

The drug XYREM contains one active pharmaceutical ingredient (API):

1 Sodium oxybate UNII 7G33012534 - SODIUM OXYBATE

Read about Sodium oxybate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XYREM Solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX04	Hydroxybutyric acid	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02268272
Country: EE	Ravimiamet	Identifier(s): 1220870
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 05312001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 020333
Country: FR	Base de données publique des médicaments	Identifier(s): 60913012
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 100709
Country: IE	Health Products Regulatory Authority	Identifier(s): 88567
Country: IT	Agenzia del Farmaco	Identifier(s): 036964017
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031426
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100000362
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699624650047
Country: US	FDA, National Drug Code	Identifier(s): 68727-100